YOU ARE HERE:
About HIV & AIDS Treatment in Practice
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings. It is supported by and produced in collaboration with St Stephen's AIDS Trust and the International HIV/AIDS Alliance.
Its publication is also supported by Positive Action of GlaxoSmithKline, Boehringer Ingelheim and the Access 4 Trust.
Its publication is also supported by Positive Action of GlaxoSmithKline, Boehringer Ingelheim and the Access 4 Trust.
| Last updated: 18.06.04 |
'HIV & AIDS Treatment in Practice' is an email newsletter for doctors,
nurses, health care workers and community treatment advocates working in
limited-resource settings.
It is published twice every month by NAM, the UK-based HIV information charity behind www.aidsmap.com, in partnership with the Saint Stephen's AIDS Trust.
The newsletter is edited by Theo Smart (Cape Town) and Keith Alcorn, NAM's Senior Editor (London), guided by a voluntary advisory panel whose members are listed below.
(For subscription instructions, please see below.)
Advisory Panel
A voluntary advisory panel, of 28 medical practitioners (from the public, private and NGO sectors), academic researchers and people from community organisations, working in middle-income and low-income countries, is central to this newsletter.
The members are: Simon Sadler (Australia); Michael Ali (Guyana); Vijay Anthony Prabhu (India); Chris W Green (Indonesia); Zvi Bentwich (Israel); Christopher Lee (Malaysia); Gerard van Osch (St Maarten, Netherlands Antilles); Adama Ndir (Senegal); Francesca Conradie, Harry Hausler, Desmond Martin, Catherine Orrell, Leon Regensberg, Paul Roux, Francois Venter, Douglas Wilson (South Africa); Rob Camp (Spain/USA); Pauline Ngunjiri (St Kitts and Nevis); Henry Barigye, Sowedi Muyingo, Edward Semafumu, Molly Tumusiime (Uganda); Mandeep Dhaliwal, Brian Gazzard, Anton Pozniak (UK); Jenny Lytton, Miriam Rabkin (USA); Norman Nyazema (Zimbabwe).
The panel guides the development of the newsletter and comment on key issues from their experience of implementing HIV and AIDS treatment and care. Further volunteers are welcomed.
Goals of HIV & AIDS Treatment in Practice
Our goal is to consider, in practical terms, how appropriate and effective treatment, including but not limited to ARVs, can become a reality for all who need it.
We acknowledge in this title that for medicines to be effective in the real world, other things are important besides the supply of drugs. These begin with the relationships between treatment providers and people with HIV. Beyond this, effective treatment depends on wider patterns of practical and psychological support and care within families and communities.
While the political and international financial context is very important for access to treatment and care, other forums exist for discussion of those issues and so they will not be covered in ‘HIV & AIDS Treatment in Practice’, except as links to aidsmap news stories.
Special features of the newsletter
- Each issue will review one major topic in HIV & AIDS treatment. In the first few issues, we will be looking at fixed-dose ARV combinations, implementing co-trimoxazole prophylaxis, and treating active TB while giving ARVs at the same time.
- You can order further articles, providing more detail and supplementary information, to be sent to you by e-mail. This reduces the amount of time you have to spend on the internet.
- Each newsletter will contain specialist comment from doctors with expertise in delivering ARVS and AIDS treatment in resource-limited settings.
- Each edition will contain up to date information on ARVs and how they are being used in resource-limited settings.
- All articles are medically reviewed to ensure accuracy, balance and relevance. The newsletter is NOT sponsored by any pharmaceutical company.
How to subscribe
Sign up here
For people who have internet email access only, please send an email with your name, email address and the country in which you work to: hatip@nam.org.uk
with the words “add HATIP list” in the `subject` line.
Reproduction and translation
While the newsletter is only available in English and by email (or from a web-based archive), permission for republication and distribution in different formats and translation into different languages is freely granted to community-based and not-for-profit organisations, provided the source is acknowledged and an electronic copy of any translation is supplied to NAM.
The editors have taken all such care as they consider reasonable in preparing this newsletter, but they cannot be held responsible for any inaccuracies or mis-statements of fact contained herein. Inclusion in this newsletter of any information on any treatment, therapy, or clinical trial in no way represents an endorsement of that treatment, therapy, or trial by NAM or any of the sponsors of aidsmap. This information should always be used in conjunction with professional medical advice.
About NAM
NAM was established in 1987 and has been publishing information on HIV treatment for people with HIV and health care professionals since 1991. NAM also runs an award-winning website, http://www.aidsmap.com in partnership with the International HIV/AIDS Alliance and the British HIV Association. NAM originally stood for `National AIDS Manual`, the UK’s first comprehensive guide to HIV prevention, care and services. NAM now publishes more than a dozen directories and manuals each year.
For more information about NAM and its services, click on here
aidsmap resources
Africa news
- HIV prevalence may decline because the most vulnerable are infected and die first
- TB doesn't always increase HIV viral load
- Circumcision may offer men some protection against HPV
Asia and Pacific news
- Starting HIV treatment doesn't increase neuropathy rate in Thai study
- Chinese HIV prevention with drug users undermined by police
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
Eastern Europe and Russia news
- HIV diagnoses in European MSM have almost doubled since 2000, UK tops the list
- Long hospital stays for TB treatment can increase risk of reinfection with MDR or XDR-TB strains
- Long hospital stays for TB treatment can increase risk of reinfection with MDR or XDR-TB strains
Latin America news
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Brazil rejects tenofovir patent
- Immigration and prevention: the effect of migration on risk behaviour
Middle East news
- Justice Edwin Cameron calls for a campaign against 'misguided criminal laws and prosecutions'
- Half of all new HIV infections could be averted if proven prevention efforts expanded
- Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated
Treatment access news
- Study highlights bottlenecks in ARV supply in West Africa
- Governments in southern Africa need to work harder at treatment scale-up, say activists
- Botswana expects HIV treatment numbers to reach 225,000 by 2016
